Loading candles…
Samrat Pharmachem Ltd, incorporated in 1992 as a public limited company and headquartered in Mumbai, operates in the pharmaceutical and specialty chemicals industries. The company manufactures and sells iodine-based pharmaceutical and specialty chemicals that serve as essential inputs for sectors including healthcare, animal nutrition, electronics, and textiles. It focuses primarily on the production and export of these chemicals. There are no listed subsidiaries, notable projects, or exchange listings associated with the company in the provided information.
This page is a live market overview for SAMRAT PHARMACHEM LTD. (SAMRATPH) on the BSE. As a listed security, SAMRAT PHARMACHEM LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SAMRATPH before placing trades on tick2trade.
As of the latest feed, SAMRATPH last traded at ₹253.85 on BSE, up ₹11.95 (4.94%) from the previous close of ₹241.9. Today's session range is ₹235 – ₹253.95, against a 52-week band of ₹235 – ₹490.95. Traded volume today stands at 3.31K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for SAMRATPH in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SAMRATPH is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SAMRAT PHARMACHEM LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SAMRATPH. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SAMRATPH option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.